Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Analytical and Bioanalytical Chemistry|April 24, 2015
Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testingMarisol S Castaneto, Allan J Barnes, Marta Concheiro, et al.
Therapeutic Drug Monitoring|May 21, 2015
Urine Mescaline Screening With a Biochip Array Immunoassay and Quantification by Gas Chromatography-Mass SpectrometryDilek Battal, Allan J Barnes, Marisol S Castaneto, et al.
Drug Testing and Analysis|August 30, 2014
Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoidsEliani Spinelli, Allan J Barnes, Sheena Young, et al.
Bioanalysis|December 9, 2014
Method validation of the biochip array technology for synthetic cannabinoids detection in urineMarisol S Castaneto, Nathalie A Desrosiers, Kayla Ellefsen, et al.
Drug Testing and Analysis|September 19, 2014
Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimensMarisol S Castaneto, Karl B Scheidweiler, Adarsh Gandhi, et al.
Clinical Chemistry|June 21, 2003
Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humansRichard A Gustafson, Barry Levine, Peter R Stout, et al.
Drug Testing and Analysis|March 25, 2014
Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array TechnologyKayla N Ellefsen, Sébastien Anizan, Marisol S Castaneto, et al.
Clinical Chemistry and Laboratory Medicine|September 30, 2014
Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimensAriane Wohlfarth, Karl B Scheidweiler, Marisol Castaneto, et al.
Journal of Analytical Toxicology|April 27, 2004
Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administrationRichard A Gustafson, Insook Kim, Peter R Stout, et al.
Pageof 3